Alnylam Pharmaceuticals, Inc. (ALNY)

Alnylam Pharmaceuticals Market Cap

Alnylam Pharmaceuticals has a market cap or net worth of $23.28 billion as of October 29, 2026. It is the 803rd most valuable company in the world and the 356th biggest in the United States. Its market cap has decreased by 62.68% in one year.

• Market Cap: 23.28B
• Enterprise Value: 22.96B
• 1-Year Change: -62.68%
• Global Rank: #803
• Country Rank: #356 United States
• Category: Large-Cap

Market Cap Chart

Chart

Since June 1, 2004, Alnylam Pharmaceuticals's market cap has increased from $135.00M to $23.28B, an increase of 17,146.51%. That is a compound annual growth rate of 25.82%.

Market Cap History

Date	Market Cap	% Change
Oct 29, 2026	23.28B	-55.68%
Dec 31, 2025	52.54B	73.09%
Dec 31, 2024	30.35B	26.35%
Dec 29, 2023	24.02B	-17.84%
Dec 30, 2022	29.24B	44.16%
Dec 31, 2021	20.28B	34.32%
Dec 31, 2020	15.10B	17.60%
Dec 31, 2019	12.84B	74.32%
Dec 31, 2018	7.37B	-37.48%
Dec 29, 2017	11.78B	266.69%
Dec 30, 2016	3.21B	-59.72%
Dec 31, 2015	7.98B	6.90%
Dec 31, 2014	7.46B	82.96%
Dec 31, 2013	4.08B	326.36%
Dec 31, 2012	956.60M	174.73%
Dec 30, 2011	348.20M	-16.32%
Dec 31, 2010	416.10M	-43.53%
Dec 31, 2009	736.80M	-28.05%
Dec 31, 2008	1.02B	-13.48%
Dec 31, 2007	1.18B	71.64%
Dec 29, 2006	689.60M	94.42%
Dec 30, 2005	354.70M	136.47%
Dec 31, 2004	150.00M	11.11%
Jun 1, 2004	135.00M	-

View and export this data all the way back to 2004. Sign Up Today.

Data Source: Nasdaq Data Link Last updated: Oct 28, 2026

Market cap data is provided by Nasdaq Data Link. The current market cap updates continuously throughout the trading day, while the historical market cap is updated daily after market close.

Update frequency:

Daily

Last checked:

Oct 29, 2026

Data Sources Report a data error

Related Stocks

Company	Market Cap
argenx SE	54.57B
BeOne Medicines AG	42.17B
Revolution Medicines	39.42B
Royalty Pharma	37.24B
Genmab	26.50B
Roivant Sciences	26.04B
Incyte	22.97B
BioNTech SE	21.82B